Search

everythinglearnresearchcommunity

for

Search:↓

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

Plerixafor may help treat pigmentation disorders by promoting skin repigmentation.

Finasteride may improve prostate cancer therapy by enhancing testosterone's benefits and reducing risks.

Oral tofacitinib can treat both psoriasis and alopecia universalis by normalizing inflammatory pathways.

Urologists prescribe newer medications more often than primary care physicians, who could benefit from more education on treatment options.

Blocking JAK1 or JAK3 helps reverse hair loss in a mouse model of alopecia areata.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

A blood pressure drug, diltiazem, may also help treat influenza.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Tyrosine kinase inhibitors effectively treat cancers but often cause skin and other side effects.

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.

JAK inhibitors show promise in treating moderate to severe alopecia areata.

JAK inhibitors offer new hope for treating severe alopecia areata.

A girl with Evans' syndrome had her low platelet count successfully treated with zanubrutinib.

5α-reductase inhibitors, like Finasteride and Dutasteride, help manage benign prostatic hyperplasia.

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.

Potassium channel openers help form elastic fibers in arteries and can treat elastin deficiency and hypertension.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

Isotretinoin shows promise as a treatment for Chagas disease by effectively inhibiting key transporters in the parasite.

Upadacitinib may effectively treat both alopecia universalis and Crohn's disease.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

Baricitinib is the most effective treatment for alopecia areata.

Brassinosteroids may be useful in treating cancer, infections, and other diseases.

Optimizing the structure of a specific compound greatly improved its effectiveness and precision for treating diabetic complications.

A new anti-baldness patch effectively treats hair loss by blocking enzymes linked to the condition.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

Tyrosine kinase inhibitors show promise in treating some skin diseases but their definitive role in dermatology is still unclear.

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.